TEIJIN (3401) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The current period produced a challenging set of results, with the Company falling into an operating loss primarily due to substantial impairment losses, alongside a decline in underlying earnings power. Revenue was ¥6,598.8B (-12.7% year on year), Operating Income was ¥-537.7B (deteriorating from ¥-437.3B in the previous year), Profit Before Tax was ¥-558.8B, and Net Income attributable to owners of the parent was ¥-589.7B (a significant YoY deterioration from ¥526.3B in the previous year). The ¥608.4B impairment loss was the direct cause of the expanded loss; however, even excluding this loss, the Operating Income margin remained approximately 1.1%. This confirms structurally weak profitability, with a gross margin of 17.6% unable to absorb the SG&A expense ratio of 24.0%.

Factors Affecting Results

【Revenue】Revenue was ¥6,598.8B, down 12.7% year on year. The gross margin was 17.6% (gross profit of ¥1,164.2B), with lower demand and volume weakening the absorption of fixed costs.

【Profit and Loss】SG&A expenses of ¥1,586.7B exceeded gross profit. In addition, the ¥608.4B impairment loss weighed on operating results, resulting in Operating Income of ¥-537.7B (¥-437.3B in the previous year). Net financial expenses also placed a burden on earnings, as financial expenses exceeded financial income, resulting in Profit Before Tax of ¥-558.8B. The recognition of ¥30.3B in income taxes and other taxes resulted in a negative effective tax rate, and tax effects did not mitigate the loss. Net Income attributable to owners of the parent was ¥-589.7B, with the impairment loss equivalent to approximately 103% of the loss. In conclusion, the Company experienced lower revenue and lower profit, with a substantial expansion of the loss accompanied by impairment recognition.

Key Financial Indicators

【Profitability】The Operating Income margin was -8.1%, while the underlying Operating Income margin excluding impairment losses remained approximately 1.1%. The gross margin of 17.6% is structurally below the SG&A expense ratio of 24.0%. ROE was -15.1%, and the Profit Before Tax margin was also negative, making a recovery in earnings exceeding the cost of capital a key challenge.【Cash Flow Quality】Operating Cash Flow (OCF) was positive at ¥731.7B, indicating cash generation in the opposite direction from the net loss of ¥589.7B; however, this included the temporary working-capital benefit of a ¥140.1B decrease in inventories and a ¥39.8B decrease in trade receivables.【Investment Efficiency】Despite capital expenditures of ¥439.4B, the Company secured Free Cash Flow of ¥311.1B, with OCF exceeding investment outlays.【Financial Soundness】The Equity Ratio was 39.1% (down from 40.6% in the previous year). Total assets were ¥9,896.4B and net assets were ¥3,911.9B. Although the Company has not reached an excessive level of leverage at present, the erosion of capital warrants attention.

Cash Flow Analysis

OCF was positive at ¥731.7B, up +79.2% year on year, demonstrating cash-generating capacity in contrast to the accounting net loss of ¥589.7B. However, the improvement into positive territory was supported by a ¥140.1B decrease in inventories and a ¥39.8B decrease in trade receivables, while a ¥99.7B decrease in trade payables was a negative factor. Accordingly, the cash inflow partly reflects a temporary reduction in inventories and receivables. Investing Cash Flow (ICF) was ¥-420.6B, reflecting continued cash outflows centered on ¥439.4B in capital expenditures. Financing Cash Flow (FCF) was ¥-216.1B and included ¥96.4B in dividend payments. As a result, the Company secured positive Free Cash Flow of ¥311.1B, and cash and cash equivalents accumulated to ¥1,221.7B. Going forward, the key issue will be whether the quality of cash generation can be improved through enhanced profitability, without relying on reductions in inventories and trade receivables.

Earnings Quality

The primary cause of the current-period loss was the one-time ¥608.4B impairment loss. Excluding this item, underlying Operating Income was approximately ¥70.7B, corresponding to an Operating Income margin of 1.1%. Below Operating Income, financial income of ¥31.8B was recorded against financial expenses of ¥77.0B, with net financial expenses expanding the loss. Equity-method investment income of ¥24.1B provided some support but was insufficient to offset the deficit in the consolidated core business. Comprehensive income was ¥-346.2B (¥-346.9B attributable to owners of the parent). The divergence from Net Income of ¥-589.7B was primarily attributable to other comprehensive income items, including foreign currency translation adjustments. Although OCF was positive at ¥731.7B, its components included working-capital factors such as decreases in inventories and trade receivables. Therefore, the divergence in direction between accounting profit and cash flow can be interpreted as primarily resulting from the significant amount of non-cash impairment expense.

Earnings Forecast and Guidance

The full-year Company plan calls for Revenue of ¥8,600.0B, Operating Income of ¥50.0B, forecast EPS of -¥51.85, and forecast dividends of ¥50.00. The Revenue progress rate was 76.7% (Q3 cumulative Revenue of ¥6,598.8B), slightly exceeding the standard 75% level. However, Operating Income was a loss of ¥-537.7B on a Q3 cumulative basis, requiring a sharp recovery to ¥587.7B of Operating Income in Q4 alone, equivalent to an Operating Income margin of 29.4%, to achieve the full-year plan. For Net Income, the full-year forecast is a loss of ¥-100.0B, while a loss of ¥-589.1B was recorded on a Q3 cumulative basis, requiring a return to profitability of approximately ¥489.1B in Q4. There is a substantial divergence between Revenue progress and earnings progress, and the achievability of the full-year plan requires verification through future results.

Shareholder Returns

The Q2 dividend was ¥25.00 per share, with total dividend payments of ¥96.4B. The full-year dividend forecast is ¥50.00 per share, representing a planned increase from the previous year’s dividend. Share buybacks were virtually nonexistent (¥0.0B), making dividends the primary form of shareholder return. As the Company recorded a net loss for the current period, the Payout Ratio cannot be calculated as a meaningful indicator. However, Free Cash Flow of ¥311.1B exceeded the expected annual total dividends of approximately ¥99.0B, based on the number of shares outstanding, indicating that dividend funding is secured from a cash flow perspective for the time being. Nevertheless, if operating losses continue, the sustainability of ongoing dividend payments will require monitoring based on the recovery of operating earnings.

Risk Factors

1. Profitability and impairment recurrence risk: The Operating Income margin was -8.1% and remained only 1.1% even after excluding impairment losses, with the gross margin of 17.6% unable to absorb SG&A expenses. The ¥608.4B impairment loss reflects deteriorating asset profitability, and the risk of further asset valuation revisions remains if the recovery of business earnings is delayed.

2. Demand, pricing, and fixed-cost absorption risk: Revenue decreased 12.7% year on year. Weakness in sales volume and pricing could worsen capacity utilization and fixed-cost absorption, making the impact on profit more pronounced through the low-gross-margin structure.

3. Full-year plan achievement risk: Achieving the full-year Operating Income plan of ¥50.0B requires Q4 Operating Income of ¥587.7B alone, equivalent to an Operating Income margin of 29.4%, making the plan dependent on a rapid improvement from the Q3 cumulative results.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability was significantly below the industry median, placing the Company in the lower tier of the manufacturing industry.

Growth and Capital Efficiency

Revenue growth was also significantly below the industry median, confirming the severity of demand conditions in the industry comparison.

※Source: Compiled by the Company

Key Earnings Highlights

1. The substantial ¥608.4B impairment loss was the primary cause of the current-period loss. However, the Operating Income margin excluding impairment losses remained only 1.1%, making recovery in the profitability of the core business the key focus going forward.

2. OCF of ¥731.7B and Free Cash Flow of ¥311.1B demonstrate cash-generating capacity. However, these figures include working-capital factors such as decreases in inventories and trade receivables, requiring the sustainability of cash generation to be assessed together with progress in profitability improvement.

3. The full-year Company plan assumes a substantial return to profitability in Q4, and the divergence from actual results will be the most important point to monitor in future earnings releases.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,351–¥1,429 at ±1% in the cost of equity, and ¥1,370–¥1,402 at ±0.1 in ω.

Notes:

• Since forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Teijin’s FY2026 Q3 result was operationally weak and dominated by a large impairment charge, although operating cash generation remained positive. Revenue for the nine-month cumulative period fell 12.7% year on year to ¥659.9bn. Gross profit declined to ¥116.4bn, and the gross margin contracted 60bp year on year to 17.6% from 18.2%. Reported operating loss widened to ¥53.8bn from a ¥43.7bn loss in the prior-year period. The reported operating margin deteriorated by 240bp to -8.2%. A ¥60.8bn impairment loss recorded in operating expenses was the principal driver of the reported operating loss. Excluding that impairment mechanically, operating income would have been approximately ¥7.1bn, equivalent to a modest 1.1% margin, showing that underlying profitability remains weak even before the non-cash charge. Net loss attributable to owners was ¥59.0bn, versus a ¥51.0bn profit a year earlier. The year-on-year swing in net income is not directly comparable because the prior-year result included ¥106.1bn of profit from discontinued operations, whereas the current-period result reflects a loss from continuing operations. Finance costs of ¥7.7bn exceeded finance income of ¥3.2bn, adding to the loss below operating income. Operating cash flow was nevertheless strong at ¥73.2bn, aided by the impairment add-back and favorable inventory and receivables movements. Cumulative free cash flow was positive at ¥31.1bn after ¥43.9bn of capital expenditure. The balance sheet retains a 39.1% equity ratio and a current ratio of approximately 1.72x, so immediate liquidity appears adequate. However, inventories represent 22.6% of total assets, while the 113-day inventory cycle and 133-day cash conversion cycle point to substantial working-capital intensity. The FY2026 full-year plan calls for revenue of ¥860.0bn, operating income of ¥5.0bn and a net loss attributable to owners of ¥10.0bn. Achieving that plan requires an approximately ¥58.8bn operating-profit turnaround and approximately ¥49.0bn net-profit improvement in Q4 alone, making execution in the final quarter the central earnings issue. The planned ¥50 annual dividend is cash-flow covered on the reported cumulative free-cash-flow basis, but it is not covered by earnings and therefore depends on balance-sheet capacity and recovery in underlying profitability.

Profitability Analysis

The reported annualized DuPont ROE is -20.1%, comprising a -8.9% net profit margin, 0.889x asset turnover and 2.53x financial leverage. The negative net margin is the dominant cause of the negative ROE; asset turnover is reasonable for a diversified materials manufacturer, while leverage magnifies the loss attributable to equity holders. The -8.2% EBIT margin is materially below the 5% minimum profitability benchmark and worsened from approximately -5.8% in the prior-year period. Gross margin fell to 17.6% from 18.2%, a 60bp compression, indicating that lower sales were not fully offset by cost absorption or pricing actions. SG&A expenses fell 12.2% to ¥158.7bn, broadly in line with the 12.7% decline in revenue, so there is no evidence from the available figures that SG&A deleveraged relative to sales. The main reported earnings distortion is the ¥60.8bn impairment charge included in operating expenses. This charge exceeds the reported operating loss, and its recurrence risk depends on whether the impaired businesses can achieve their revised cash-flow assumptions. On a mechanical pre-impairment basis, operating income would be roughly ¥7.1bn, but the corresponding 1.1% margin remains far below a satisfactory level for the capital employed. Interest burden was 1.039x because profit before tax was more negative than EBIT, while the tax burden was 1.055x due to a tax expense despite a pre-tax loss. The negative effective tax rate of -5.4% indicates limited tax shielding in the period and weak conversion of operating losses into tax benefits. The quality alert for low operating efficiency is therefore warranted: the root cause is a combination of a low 17.6% gross margin, lower revenue and the impairment charge; the impact is that a recovery in reported ROE requires both restoration of core margins and avoidance of further asset write-downs. The quality alert for ROIC of -18.3% is also material: returns are below the cost of capital because the operating loss is being generated against a large ¥989.6bn asset base; the impact is heightened pressure to improve portfolio returns, reduce capital tied up in operations or both.

Growth Assessment

Revenue declined 12.7% year on year to ¥659.9bn, indicating that the earnings challenge is not solely impairment-related but also reflects a lower sales base. Gross profit decreased 15.2% to ¥116.4bn, faster than revenue, consistent with the 60bp gross-margin contraction. The multi-period consistency score of 2/10 reinforces that recent earnings delivery has been volatile. The current FY2026 Q3 revenue progress rate is 76.7% of the ¥860.0bn full-year forecast, modestly above the standard 75% Q3 pace. By contrast, operating income is deeply below the ¥5.0bn full-year target because the cumulative operating loss is ¥53.8bn. The implied Q4 operating profit required to meet guidance is approximately ¥58.8bn. Net income attributable to owners is also substantially behind the ¥10.0bn full-year loss forecast, requiring an implied Q4 profit of about ¥49.0bn. Such a final-quarter reversal likely requires a combination of impairment normalization, meaningful underlying operating improvement and/or favorable non-operating or portfolio effects. Equity-method investment income was ¥2.4bn and is not large enough to alter the overall earnings trajectory. The prior-year net profit included a sizable discontinued-operations gain, so the apparent year-on-year deterioration in net income should not be interpreted solely as a decline in recurring operations. The key determinant of revenue sustainability is whether demand and pricing can stabilize while the group reduces the working capital required to support sales. For a manufacturing and materials business, prolonged inventory holding also raises the risk of future pricing pressure, lower utilization and additional valuation adjustments if demand remains soft.

Financial Health

Liquidity is acceptable based on current assets of ¥573.2bn against estimated current liabilities of ¥334.1bn, producing a current ratio of approximately 1.72x. The estimated quick ratio is approximately 1.04x after excluding ¥224.1bn of inventories, which is above 1.0x but leaves limited headroom if inventory monetization slows. Working capital is positive at approximately ¥239.1bn, calculated as current assets less estimated current liabilities. Cash and cash equivalents were ¥122.2bn. Interest-bearing bonds and borrowings totaled ¥362.5bn, comprising ¥170.9bn current and ¥191.7bn non-current balances. Current borrowings alone exceed cash, meaning refinancing access and operating cash flow remain important for short-term debt management. Lease liabilities totaled ¥25.8bn, including ¥7.6bn current and ¥18.1bn non-current. The reported debt-to-equity ratio is 1.53x, below the 2.0x aggressive-financing warning threshold but elevated relative to a conservative capital structure. Total liabilities represented 60.5% of total assets and the equity ratio declined to 39.1% from 40.6% a year earlier. Retained earnings fell ¥67.6bn, or 29.2%, year on year to ¥164.2bn, principally reflecting the current loss and shareholder distributions; this reduces the buffer available to absorb future restructuring costs or impairments. Defined-benefit obligations of ¥37.1bn and lease liabilities are additional fixed claims to monitor. Goodwill is modest at ¥8.6bn, equal to 2.2% of equity and 0.9% of assets, limiting balance-sheet dependence on acquisition value retention. Intangible assets of ¥75.5bn represent 7.6% of assets, also below concentration-warning levels. Assets held for sale of ¥14.1bn should be monitored as part of the portfolio restructuring process.

Notable B/S Changes

Retained earnings: -¥67.6bn (-29.2%) year on year to ¥164.2bn - cumulative losses and shareholder distributions have reduced the equity buffer available for restructuring, impairments and dividends.

Cash Flow Quality

Operating cash flow was ¥73.2bn for the nine-month cumulative period, materially above the ¥59.0bn net loss. The reported OCF/net income ratio of -1.24x triggers the earnings-quality alert, but the negative ratio is not economically interpretable in the normal way because the denominator is negative. Its root cause is the large loss, particularly the ¥60.8bn non-cash impairment charge, rather than an inability to generate cash from operations. Cash conversion was supported by a ¥14.0bn inventory-related cash inflow and a ¥4.0bn receivables-related inflow. These favorable movements were partly offset by a ¥10.0bn payables outflow. The negative accruals ratio of -13.3% is consistent with cash flow exceeding accounting earnings, but this should not be treated as evidence of sustainably strong cash earnings because impairment add-backs are non-recurring in cash-flow terms. The quality alert is therefore best characterized as earnings distortion rather than conventional accrual-led earnings inflation. Capital expenditure was ¥43.9bn, equivalent to 6.7% of nine-month revenue, within the typical 3-8% manufacturing range. After capital expenditure, cumulative free cash flow was positive at ¥31.1bn. Investing cash outflow also included ¥4.7bn of intangible asset purchases, while proceeds from subsidiary sales were ¥4.1bn. Financing cash flow was a ¥21.6bn outflow, including ¥36.8bn of long-term debt repayments, partly offset by a ¥29.3bn increase in short-term borrowings. Cash increased by ¥12.9bn over the period to ¥122.2bn. The operational working-capital alerts remain material: DSO of 70 days is above the 60-day warning threshold, DIO of 113 days is above both the 90-day and 60-day warning benchmarks, and the 133-day cash conversion cycle exceeds the 120-day warning level. The root cause is the large inventory base and slow receivables collection relative to manufacturing benchmarks; the impact is greater cash lock-up, higher obsolescence risk and vulnerability if volumes or selling prices weaken.

Dividend Sustainability

The company paid an interim dividend of ¥25 per share and forecasts a full-year dividend of ¥50 per share. At approximately 198.0 million issued shares, the full-year cash dividend commitment is about ¥9.9bn before considering the effect of treasury shares. The reported payout ratio is negative because the company recorded a net loss; accordingly, earnings do not cover the dividend. Cumulative free cash flow of ¥31.1bn covers the estimated full-year dividend by roughly 3.1x, although this is based on nine-month cumulative cash flow and should not be regarded as a full-year recurring coverage ratio. The reported 6.29x FCF coverage appears to relate to the interim distribution rather than the full-year ¥50 per-share commitment. Share repurchases were immaterial at ¥0.003bn, so shareholder return is almost entirely dividend-based. The dividend is therefore currently supported by cash generation and liquidity rather than profits. Sustained payment at the planned level depends on a return to positive underlying operating income, disciplined capital expenditure and no material repetition of impairment-related restructuring costs. The decline in retained earnings and the need for a large Q4 recovery make dividend policy sensitivity an important monitoring point.

Risk Assessment

Business risks include Demand, pricing and utilization risk: revenue declined 12.7% and gross margin fell to 17.6%, leaving the business vulnerable to continued volume weakness and insufficient fixed-cost absorption., Inventory risk: DIO of 113 days and inventories of ¥224.1bn create elevated risks of obsolescence, inventory valuation pressure and further cash absorption if end-market demand weakens., Working-capital risk: DSO of 70 days and a 133-day cash conversion cycle indicate slow conversion of sales into cash and increase sensitivity to customer collection behavior., Manufacturing cost risk: low gross margin leaves limited capacity to absorb adverse movements in raw-material, energy, logistics and labor costs., Portfolio and impairment risk: the ¥60.8bn impairment indicates that some asset cash-flow assumptions have been reset; further underperformance could result in additional write-downs or restructuring costs..

Financial risks include Profitability and capital-efficiency risk: reported EBIT margin was -8.2%, annualized ROE was -20.1%, and ROIC was -18.3%, which erodes equity value if not reversed., Refinancing and maturity risk: current bonds and borrowings of ¥170.9bn exceed cash of ¥122.2bn, requiring continued access to bank and capital-market funding., Leverage risk: D/E of 1.53x is not above the 2.0x warning threshold but is elevated while earnings are negative and the equity ratio has fallen to 39.1%., Dividend funding risk: the planned ¥50 dividend is not earnings-covered and would rely on cash flow and balance-sheet capacity until profitability recovers., Interest-cost risk: finance costs of ¥7.7bn exceeded finance income by ¥4.5bn, adding pressure during a period of operating losses..

Key concerns include Highest priority: delivery of the implied approximately ¥58.8bn Q4 operating-profit swing required to meet full-year guidance., Highest priority: whether the impairment charge is a one-time portfolio reset or a signal of continued structural weakness in affected operations., High priority: reduction of the 113-day inventory cycle and 133-day cash conversion cycle without sacrificing pricing or incurring further write-downs., High priority: preservation of cash flow while funding approximately ¥43.9bn of nine-month capital expenditure, debt repayment and dividends., Industry-specific concern: materials and manufacturing operations remain exposed to cyclical industrial demand, input-cost inflation and inventory valuation risk..

Investment Implications

Key takeaways include Reported losses were heavily affected by a ¥60.8bn impairment, but the mechanical pre-impairment operating margin of roughly 1.1% still demonstrates weak core profitability., Positive cumulative free cash flow of ¥31.1bn and a 1.72x current ratio provide near-term liquidity support., Working-capital efficiency is weak, with 70 DSO, 113 DIO and a 133-day cash conversion cycle., The balance sheet is not goodwill-heavy, as goodwill is only 2.2% of equity, reducing a major source of acquisition-related impairment risk., Full-year guidance embeds an unusually large Q4 earnings recovery, which makes execution and the absence of further exceptional charges critical..

Metrics to watch include Quarterly operating margin and gross-margin recovery from the current -8.2% and 17.6%, respectively., Any further impairment, restructuring expense or asset-disposal impact., Inventory balance and inventory days relative to the current ¥224.1bn and 113 days., Receivable days and cash conversion cycle relative to 70 days and 133 days., Short-term borrowing levels, refinancing activity and net finance costs., Full-year operating-income and net-income delivery versus the ¥5.0bn operating-profit and ¥10.0bn net-loss forecasts., Dividend guidance relative to free cash flow and retained earnings..

Regarding relative positioning, Relative to healthy manufacturing benchmarks, Teijin currently screens poorly on operating margin, ROIC and working-capital efficiency. Relative to highly acquisitive or intangible-heavy companies, its goodwill and intangible-asset exposure is modest, which limits balance-sheet valuation risk. The central analytical distinction is between reported losses caused by impairment and the still-low underlying operating profitability that must improve for a durable recovery.